N@N

Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences

^{Published on 2010-11-08 04:35:16 - Market Wire}
 

ROCKVILLE, Md.--([ BUSINESS WIRE ])--Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the following investor conferences during the months of November and December 2010.

• The Lazard Capital Markets 7^th Annual Healthcare Conference 2010
  New York, NY.
  November 17, 2010
  Presentation Time: 1:45 PM Eastern

• The J.P. Morgan SMid Cap Conference 2010
  New York, NY.
  December 2, 2010
  Presentation Time: 2:15 PM Eastern

During each presentation, a member of the companya™s senior management team will provide a corporate overview, including a discussion of product development programs, corporate activities and financial performance.

A webcast of these presentations will be available both live and by replay, accessible from the companya™s website [ www.emergentbiosolutions.com ] under aInvestorsa.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a global biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodya™s immune system to prevent or treat disease. Emergenta™s marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information may be found at [ www.emergentbiosolutions.com ].